#Covovax for children

[supernews]

Covovax now available for children in India: SII CEO Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the COVID-19 vaccine Covovax is now available in India for children.

He also hailed Prime Minister Narendra Modi for his vision of providing another vaccine for children.

Covovax (Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of 90 per cent. This is in line with Prime Minister Narendra Modi's vision of providing yet another vaccine to protect our children," he said in a tweet.

Last week, the National Technical Advisory Group on Immunisation (NTAGI) approved the Serum Institute of India's Covovax COVID-19 vaccine for the age group 12-17.

However, the Drugs Controller General of India's (DCGI) subject expert committee has sought more data from the Pune-based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.

COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin. The drive later expanded on March 16 to include children aged above 12 for Biological E's Corbevax.

Read more

[tezlivenews]

दिसंबर के पहले हफ्ते से शुरू हो सकता है बच्चों का वैक्सीनेशन, जानें किन्हें मिलेगी प्राथमिकता

दिसंबर के पहले हफ्ते से शुरू हो सकता है बच्चों का वैक्सीनेशन, जानें किन्हें मिलेगी प्राथमिकता

Covid Vaccination of Children: बच्चों की वैक्सीन के लिए जायकोव डी, कोवैक्सिन, बायोलॉजिकल ई और सीरम इंस्टिट्यूट की कोवोवैक्स कतार में है. लेकिन दिसंबर की शुरुआत में बच्चों को जायकोव डी और कोवैक्सिन लगाने की योजना है. केंद्र सरकार के मुताबिक कई देशों में बच्चों को कोरोना का टीका दिया जा रहा है जिसपर वह नजर बनाए हुए है. Source link

[ewnsnews]

Covid: Serum Institute of India gets nod for trials of Covovax in children

Covid: Serum Institute of India gets nod for trials of Covovax in children

Serum Institute of India (SII) on Tuesday received permission to conduct phase II and III clinical trials of Covovax, the Indian version of the US biotechnology firm Novavax’s Covid-19 vaccine, in children between seven and 11 years of age. This makes it the third Covid-19 vaccine to be tested in children in India, after Bharat Biotech’s Covaxin and Zydus Cadila’s ZyCoV-D. The subject expert…

[hindimaster]

Serum Institute Of India Covovax Covid 19 Vaccine Approved By DCGI For Children Between Age Group 7 12 Years: Sources

Serum Institute Of India Covovax Covid 19 Vaccine Approved By DCGI For Children Between Age Group 7 12 Years: Sources

Covovax Vaccine: देश में कोविड के मामले एक बार फिर से बढ़ते हुए दिखाई दे रहे हैं. ऐसे में लोगों को सावधानी फिर से बरतने की जरूरत है. देश की राजधानी दिल्ली (NCT Delhi Covid Cases) में पिछले 24 घंटों में 874 कोविड के नए मामले दर्ज किए गए हैं. जिससे कोविड के सक्रिय मामले बढ़कर 4,482 हो गए हैं. वहीं इस बीच एक बड़ी राहत की खबर ये आई है कि अब 7 साल से 12 साल के बच्चों को भी वैक्सीन की खुराक दी जा…

[indianfitnesscare]

Covovax Approved for Kids Aged 7 to 11 Years

Covovax Approved for Kids Aged 7 to 11 Years

On June 24, the DCGI’s Subject Expert Committee had recommended emergency use authorization to Covovax vaccine for use in children aged 7-11. As per the source, the DCGI has also approved India’s first indigenously developed mRNA vaccine against Covid-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above. The DCGI had approved Covovax for…

[thenetionalnews]

Covovax May Get Approval For 7-11 Year Olds, Experts Recommend

Covovax May Get Approval For 7-11 Year Olds, Experts Recommend

According to the Ministry of Health, India’s total vaccination coverage has exceeded 196.94 crore (1,96,94,40,932), out of which more than 3.62 crore first doses have been administered to children in the age group of 12-14 years. The National Drugs Controller approved vaccination for children under 5 years of age on 26 April, following which the Biological-E vaccine Corbevax began to be…

[sisiranair]

NTAGI meeting on vaccination for 5-12-year-olds inconclusive: Sources

India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained inconclusive on Wednesday, according to sources.

The NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no decision on whether to expand the program to this younger group was taken.

Last month the regulator had approved two vaccines--Serum Institute's Covovax and Biological E-made Corbevax--for use in 5-12-year-old children.

However the NTAGI decides on whether these would be used in India's Covid-19 vaccination programme.

Read Complete Article

[tezlivenews]

कोरोना वैक्सीन कोवोवैक्स का बच्चों पर परीक्षण, 02-17 उम्र के वॉलिंटियर्स की भर्ती शुरू

कोरोना वैक्सीन कोवोवैक्स का बच्चों पर परीक्षण, 02-17 उम्र के वॉलिंटियर्स की भर्ती शुरू

नयी दिल्लीहमदर्द चिकित्सा विज्ञान एवं अनुसंधान संस्थान में दो से 17 वर्ष की आयु के बच्चों के बीच कोविड-19 रोधी टीके कोवोवैक्स के तीन चरणों में से दूसरे चरण के नैदानिक परीक्षण के लिए स्वयंसेवियों की भर्ती रविवार को शुरू हुई। आधिकारिक सूत्रों के अनुसार यह परीक्षण 10 स्थानों पर होगा और इसमें 920 बच्चे शामिल होंगे जिनमें 12-17 और 2-11 आयु वर्ग में 460-460 बच्चे शामिल होंगे। कुछ शर्तों के साथ परीक्षण…

[mylucky137276]

NTAGI meeting on vaccination for 5-12-year-olds inconclusive: Sources

India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained inconclusive on Wednesday, according to sources.

The NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no decision on whether to expand the program to this younger group was taken.

Last month the regulator had approved two vaccines--Serum Institute's Covovax and Biological E-made Corbevax--for use in 5-12-year-old children.

However the NTAGI decides on whether these would be used in India's Covid-19 vaccination programme.

Read Complete Article

[news99alert]

Kovovax Vaccine Now Available in Private for Ages 12-17

Kovovax Vaccine Now Available in Private for Ages 12-17

Kovovax was approved on March 9 for ages 12-17, subject to certain conditions. New Delhi: Children in the age group of 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at private centers, which is being provisioned on the CoWIN portal, official sources said on Monday. He told PTI that a single dose of Kovovax would attract Rs 900 plus GST, apart from hospital service…

[noncyowen]

covid: 230 kids aged 2-6 become youngest to get Covid jabs in Covovax trial | India News

covid: 230 kids aged 2-6 become youngest to get Covid jabs in Covovax trial | India News

PUNE: A group of 230 children aged two to six have become the youngest in the country to get a Covid vaccine after they were given at least one dose during trials of the Covovax jab, manufacturer Serum Institute of India confirmed on Tuesday. The second dose will be given 21 days from now and the trial — across 10 hospital sites in the country (including two in Pune) — will conclude by May end. A…

[salam2050]

Adar Poonawalla Says Vaccine For Children In 6 Months

Adar Poonawalla Says Vaccine For Children In 6 Months

Adar Poonawalla said Serum Institute of India hopes to launch Covid vaccine for children. The world’s largest producer of vaccines, Serum Institute of India (SII), hopes to launch the Novavax COVID-19 vaccine for children in six months, the firm’s chief executive said on Tuesday. The vaccine, which SII calls Covovax, has shown good results in trials in children aged three and older, Adar…

[sachkiawaaj]

COVID-19 vaccine: Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune

COVID-19 vaccine: Phase 2/3 trials of Covovax in children between age 7 and 11 begins in Pune

New Delhi: Phase 2/3 trials of Covovax COVID-19 vaccine in children between ages 7 and 11 began in Pune`s Bharati Vidyapeeth Medical College and Hospital on Wednesday. “Pune`s Bharati Vidyapeeth Medical College Hospital began phase 2/3 trials of Covovax in children between 7 and 11 years of age on Wednesday. Nine children have been enrolled for the trial here,” said Dr Sanjay Lalwani, the Medical…

[isaurabhverma]

https://ift.tt/3kXrCqo

[fast1997]

novavax: Novavax trials to include kids from 7 to 11 | India News

novavax: Novavax trials to include kids from 7 to 11 | India News

NEW DELHI: Serum Institute of India will now include children aged seven to 11 years for clinical trials of the Novavax Covid vaccine. So far, the company was conducting trials on children of 12 to 17 years of age. The DGCI has allowed SII to expand the cohort of the trial and enrol children between seven and eleven years, sources said. The vaccine named Covovax in India is in final stage of…

[techminsolutions]

Hopeful of launching Covovax for adults in October this year: Serum CEO

Hopeful of launching Covovax for adults in October this year: Serum CEO

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. He also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishield production…